The issue of prostate cancer evaluation in men with elevated prostate-specific antigen and chronic prostatitis

Andrologia

Volumn 40, Issue 2, 2008, Pages 130-133

  Hochreiter, W W ^a  

^a KLINIK HIRSLANDEN   (Switzerland)

Author keywords

Antibiotic treatment; Chronic prostatitis; Elevated PSA; Inflammation; Prostate biopsy

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

ANTIBIOTIC THERAPY; BACTERIAL INFECTION; CANCER SCREENING; CHRONIC PROSTATITIS; CONFERENCE PAPER; DIFFERENTIAL DIAGNOSIS; HUMAN; MALE; PELVIS PAIN SYNDROME; PROSTATE BIOPSY; PROSTATE CANCER; PROSTATE HYPERTROPHY; PROSTATE SECRETION; URINARY TRACT INFECTION;

BIOPSY; CHRONIC DISEASE; DIAGNOSIS, DIFFERENTIAL; HUMANS; MALE; PROSTATE; PROSTATE-SPECIFIC ANTIGEN; PROSTATIC NEOPLASMS; PROSTATITIS;

EID: 40749086361     PISSN: 03034569     EISSN: 14390272     Source Type: Journal    
DOI: 10.1111/j.1439-0272.2007.00820.x     Document Type: Conference Paper

References (21)

1. Bahnson RR (1991) Elevation of prostate specific antigen from bacillus Calmette-Guerin-induced granulomatous prostatitis. J Urol 146 : 1368 1369.
2. Bozeman CB, Carver BS, Eastham JA, Venable DD (2002) Treatment of chronic prostatitis lowers serum prostate specific antigen. J Urol 167 : 1723 1726.
3. Carver BS, Bozeman CB, Williams BJ, Venable DD (2003) The prevalence of men with National Institutes of Health category IV prostatitis and association with serum prostate specific antigen. J Urol 169 : 589 591.
4. Dalton DL (1989) Elevated serum prostate-specific antigen due to acute bacterial prostatitis. Urology 33 : 465.
5. Eastham JA, Riedel E, Scardino PT, Shike M, Fleisher M, Schatzkin A, Lanza E, Latkany L, Begg CB (2003) Variation of serum prostate-specific antigen levels: an evaluation of year-to-year fluctuations. Jama 289 : 2695 2700.
6. Gilliland FD, Welsh DJ, Hoffman RM, Key CR (1995) Rapid rise and subsequent decline in prostate cancer incidence rates for New Mexico, 1989-1993. Cancer Epidemiol Biomarkers Prev 4 : 797 800.
7. Hasui Y, Marutsuka K, Asada Y, Ide H, Nishi S, Osada Y (1994) Relationship between serum prostate specific antigen and histological prostatitis in patients with benign prostatic hyperplasia. Prostate 25 : 91 96.
8. Jacobsen SJ, Katusic SK, Bergstralh EJ, Oesterling JE, Ohrt D, Klee GG, Chute CG, Lieber MM (1995) Incidence of prostate cancer diagnosis in the eras before and after serum prostate-specific antigen testing. Jama 274 : 1445 1449.
9. Kwak C, Ku JH, Kim T, Park DW, Choi KY, Lee E, Lee SE, Lee C (2003) Effect of subclinical prostatic inflammation on serum PSA levels in men with clinically undetectable prostate cancer. Urology 62 : 854 859.
10. Morote J, Lopez M, Encabo G, de Torres IM (2000) Effect of inflammation and benign prostatic enlargement on total and percent free serum prostatic specific antigen. Eur Urol 37 : 537 540.
11. Nadler RB, Humphrey PA, Smith DS, Catalona WJ, Ratliff TL (1995) Effect of inflammation and benign prostatic hyperplasia on elevated serum prostate specific antigen levels. J Urol 154 : 407 413.
12. Nadler RB, Collins MM, Propert KJ, Mikolajczyk SD, Knauss JS, Landis JR, Fowler JE Jr., Schaeffer AJ, Alexander RB (2006) Prostate-specific antigen test in diagnostic evaluation of chronic prostatitis/chronic pelvic pain syndrome. Urology 67 : 337 342.
13. Neal DE Jr., Clejan S, Sarma D, Moon TD (1992) Prostate specific antigen and prostatitis. I. Effect of prostatitis on serum PSA in the human and nonhuman primate. Prostate 20 : 105 111.
14. Nickel JC (2002) Treatment of chronic prostatitis lowers serum prostate specific antigen (editorial comment). J Urol 167 : 1726.
15. Potts JM (2000) Prospective identification of National Institutes of Health category IV prostatitis in men with elevated prostate specific antigen. J Urol 164 : 1550 1553.
16. Roberts RO, Bergstralh EJ, Katusic SK, Lieber MM, Jacobsen SJ (1999) Decline in prostate cancer mortality from 1980 to 1997, and an update on incidence trends in Olmsted County, Minnesota. J Urol 161 : 529 533.
17. Roberts RO, Bergstralh EJ, Lieber MM, Jacobsen SJ (2000a) Digital rectal examination and prostate-specific antigen abnormalities at the time of prostate biopsy and biopsy outcomes, 1980 to 1997. Urology 56 : 817 822.
18. Roberts RO, Bergstralh EJ, Peterson NR, Bostwick DG, Lieber MM, Jacobsen SJ (2000b) Positive and negative biopsies in the pre-prostate specific antigen and prostate specific antigen eras, 1980 to 1997. J Urol 163 : 1471 1475.
19. Schaeffer AJ, Wu SC, Tennenberg AM, Kahn JB (2005) Treatment of chronic bacterial prostatitis with levofloxacin and ciprofloxacin lowers serum prostate specific antigen. J Urol 174 : 161 164.
20. Stamey TA, Yang N, Hay AR, McNeal JE, Freiha FS, Redwine E (1987) Prostate-specific antigen as a serum marker for adenocarcinoma of the prostate. N Engl J Med 317 : 909 916.
21. Stancik I, Luftenegger W, Klimpfinger M, Muller MM, Hoeltl W (2004) Effect of NIH-IV prostatitis on free and free-to-total PSA. Eur Urol 46 : 760 764.